Where is the Crisis? Six Months After FDA, HHS Announced Plans to Schedule 7-OH, Death Toll Remains at Zero
Washington, DC — Six months after the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) announced their intent to schedule 7-hydroxymitragynine (7-OH), a naturally occurring alkaloid derived from kratom, the number of confirmed deaths linked exclusively to 7-OH still remains zero.








